LGALS3 and inflammatory bowel disease: While none of the biomarkers presented a statistically significant correlation with disease activity scores in IBD patients, a notable association (r = 0.603, p < 0.05) was observed between galectin-3 and CRP levels in patients with Crohn’s disease.